T. Rowe Price Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Buy
201,132
+34,011
+20% +$256K ﹤0.01% 2062
2025
Q4
$1.2M Sell
167,121
-40,728
-20% -$322K ﹤0.01% 2002
2025
Q3
$2.22M Buy
207,849
+13,860
+7% +$136K ﹤0.01% 1689
2025
Q2
$1.88M Buy
193,989
+7,439
+4% +$76.7K ﹤0.01% 1668
2025
Q1
$2.78M Buy
186,550
+8,258
+5% +$127K ﹤0.01% 1467
2024
Q4
$2.66M Buy
178,292
+15,064
+9% +$245K ﹤0.01% 1519
2024
Q3
$3.12M Buy
163,228
+10,226
+7% +$212K ﹤0.01% 1443
2024
Q2
$3.17M Buy
153,002
+7,797
+5% +$155K ﹤0.01% 1382
2024
Q1
$2.73M Buy
145,205
+9,491
+7% +$163K ﹤0.01% 1433
2023
Q4
$1.96M Sell
135,714
-213,819
-61% -$2.91M ﹤0.01% 1544
2023
Q3
$6.07M Hold
349,533
﹤0.01% 1147
2023
Q2
$7.27M Hold
349,533
﹤0.01% 1128
2023
Q1
$8.22M Buy
349,533
+9,292
+3% +$249K ﹤0.01% 1090
2022
Q4
$9.5M Buy
340,241
+3,036
+0.9% +$77.6K ﹤0.01% 1064
2022
Q3
$7.89M Sell
337,205
-4,078
-1% -$123K ﹤0.01% 1107
2022
Q2
$11.5M Sell
341,283
-173,955
-34% -$6.09M ﹤0.01% 1300
2022
Q1
$18M Sell
515,238
-23,347
-4% -$798K ﹤0.01% 1253
2021
Q4
$16.4M Sell
538,585
-4,991
-0.9% -$163K ﹤0.01% 1328
2021
Q3
$17.8M Sell
543,576
-220,665
-29% -$7.06M ﹤0.01% 1333
2021
Q2
$23.1M Buy
+764,241
New +$25.2M ﹤0.01% 1265

Other funds holding OGN

T. Rowe Price Associates's OGN Position: Q1 2026 in Review

T. Rowe Price Associates increased its Organon & Co (OGN) stake by 20% in Q1 2026, buying an estimated $256K and bringing the position to 201,132 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

T. Rowe Price Associates first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $23.1M in Q2 2021. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • T. Rowe Price Associates held 201,132 shares of Organon & Co worth $1.21M as of Q1 2026.
  • T. Rowe Price Associates bought 34,011 Organon & Co shares in Q1 2026, an estimated $256K.
  • Organon & Co made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2062 holding.
  • T. Rowe Price Associates first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • T. Rowe Price Associates's Organon & Co position peaked at $23.1M in Q2 2021.
  • 604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.